Possible role of neonatal infection with the asymptomatic reassortant rotavirus (RV) strain 1321 in the decrease in hospital admissions for RV diarrhea, Bangalore, India, 1988-1999

Journal of Infectious Diseases

Volumn 189, Issue 12, 2004, Pages 2282-2289

  Vethanayagam, R R ^a   Ananda Babu, M ^b   Nagalaxmi, K S ^a   Maiya, P P ^b   Venkatesh, H A ^c   Purohit, S ^d   Behl, R ^e   Bhan, M K ^e   Ward, R L ^f   Greenberg, H B ^g   Durga Rao, C ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b MS Ramaiah Medical Teaching Hospital   (India)

^c St Martha's Hospital   (India)

^d UNIVERSITY OF PUNE   (India)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; FOLLOW UP; GENETIC REASSORTMENT; HOSPITAL ADMISSION; HUMAN; HUMAN ROTAVIRUS; INDIA; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; NEWBORN SCREENING; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; RANDOMIZATION; TIME SERIES ANALYSIS; VIRUS DETECTION; VIRUS INFECTION; VIRUS STRAIN;

AGE FACTORS; CHILD, PRESCHOOL; DIARRHEA; FECES; HOSPITALIZATION; HUMANS; INCIDENCE; INDIA; INFANT; INFANT, NEWBORN; PREVALENCE; REASSORTANT VIRUSES; ROTAVIRUS; ROTAVIRUS INFECTIONS;

EID: 2942590671     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/420889     Document Type: Article

References (39)

1. Bernstein DI, Ward RL. Rotaviruses. In: Feign RD, Cherry JD, eds. Text book of pediatric infectious diseases. 4th ed. Vol 2. Philadelphia: WB Saunders Company, 1997:1901-22.
2. Parashar UB, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-72.
3. Trucker AW, Haadix AC, Bresee JS, et al. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 1998; 279:1371-6.
4. Glass RI, Bresee JS, Parashar U, et al. Rotavirus vaccines at the threshold. Nat Med 1997; 3:1324-5.
5. Bernstein DI, Sack DA, Rothstein E, et al. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomized placebo-controlled trial. Lancet 1999; 354:287-90.
6. Perez-Schael I, Guntinas MJ, Perez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997; 337:1181-7.
7. Rennels MB, Glass RI, Dennehy PH, et al. Safety and efficacy of high dose rhesus-human reassortant rotavirus vaccines-report of the National Multicenter Trial. Pediatrics 1996; 97:7-13.
8. Christie IL, Totterdell BM, Banatvala JE. Asymptomatic endemic rotavirus infections in the newborn. Lancet 1978; 1:1176-8.
9. Flores J, Midthun K, Hoshino Y, et al. Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation. J Virol 1986; 60:972-9.
10. Haffejee IE. Neonatal rotavirus infections. Rev Infect Dis 1991; 13: 957-62.
11. Sukumaran M, Gowda K, Maiya PP, et al. Exclusive asymptomatic neonatal infections by human rotavirus strains having subgroup I specificity and "long" RNA electropherotype. Arch Virol 1992; 126:239-51.
12. Cicirello HK, Das BK, Gupta A, et al. High prevalence of rotavirus infection among neonates born at hospitals in Delhi: predisposition of newborns for infection with unusual rotavirus. Pediatr Infect Dis J 1994; 13:720-4.
13. Dunn SJ, Greenberg HB, Ward RL, et al. Serotypic and genotypic characterization of human serotype 10 rotaviruses from asymptomatic neonates. J Clin Microbiol 1993; 31:165-9.
14. Das M, Dunn SJ, Wood GN, et al. Both surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (1321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirus. Virology 1993; 194:374-9.
15. Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infections: a prospective study in young children. N Engl J Med 1983; 309:72-6.
16. Bhan MK, Lew JF, Sazawal S, et al. Protection conferred by neonatal rotavirus infection against subsequent diarrhea. J Infect Dis 1993; 168: 282-7.
17. Dennehy PH, Bresee JS. Rotavirus vaccine and intussusception: where do we go from here? Infect Dis Clin North Am 2001; 15:189-207.
18. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. JAMA 1999; 282:2113-4.
19. Dunn SJ, Cross TL, Greenberg HB. Comparison of the rotavirus non-structural protein NSP1 (NS53) from different species by sequence analysis and northern blot hybridization. Virology 1994; 203:178-83.
20. Rao CD, Das M, Ilango P, et al. Comparative nucleotide and amino acid sequence analysis of the sequence-specific RNA-binding rotavirus nonstructural protein NSP3. Virology 1995; 207:327-33.
21. Boom R, Sol CJA, Salmans MMM, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28:495-503.
22. Herring AJ, Inglis NF, Ojeh CK, Snodgrass DR, Menzies JD. Rapid diagnosis of rotavirus infection by direct detection of viral nucleic acid in silver-stained polyacrylamide gels. J Clin Microbiol 1982; 16:473-7.
23. Noreiga LP, Arias LF, Lopez S, et al. Diversity of rotavirus serotypes in Mexican infants with gastroenteritis. J Clin Microbiol 1990; 28:1114-9.
24. Aijaz S, Gowda K, Jagannath HV, et al. Epidemiology of symptomatic human rotaviruses in Bangalore and Mysore, India, from 1988 to 1994 as determined by electropherotype, subgroup and serotype analysis. Arch Virol 1996; 141:715-26.
25. Jagannath MR, Vethanayagam RR, Reddy BSY, et al. Characterization of human symptomatic rotavirus isolates MP409 and MP480 having "long" RNA electropherotype and subgroup I specificity, highly related to the P6[1],G8 type bovine rotavirus A5, from Mysore, India. Arch Virol 2000; 145:1339-57.
26. Rao CD, Jagannath MR, Varshney BC, Das M, Reddy BSY. Genomic diversity through gene reassortment and antigenic drift and molecular epidemiology of rotaviruses in India. In: Kobayashi N, ed. Genomic diversity and molecular epidemiology of rotaviruses. Trivandrum: Research Signpost, 2003:55-74.
27. Mahajan NP, Rao CD. Nucleotide sequence and expression in E. coli of the complete P4 type VP4 from a G2 serotype human rotavirus. Arch Virol 1996; 141:315-29.
28. Das M. Genetic characterization of novel asymptomatic neonatal human rotavirus 1321 and studies on the structure and expression of the major rotavirus neutralization antigen VP7 [thesis]. Bangalore, India: Indian Institute of Science, 1996.
29. Bhan MK, Raj P, Bhandari N, et al. Role of enteric adenoviruses and rotaviruses in mild and severe acute enteritis. Pediatr Infect Dis J 1988; 7:320-3.
30. Cook SM, Glass RI, Le Baron CW, Ho MS. Global seasonality of rotavirus infections. Bull World Health Organ 1990; 68:171-7.
31. Gentsch J, Das BK, Jiang B, et al. Similarity of the VP4 protein of human rotavirus strain 116E to that of the bovine B223 strain. Virology 1993; 194:424-30.
32. Varshney B, Jagannath MR, Vethanayagam RR, et al. Prevalence of, and antigenic variation in serotype G10 rotaviruses and detection of serotype G3 strains in diarrheic calves: implications for the origin of G10P11 or P11 type reassortant asymptomatic strains in newborn children in India. Arch Virol 2002; 147:143-67.
33. Ward RL, Clemens JD, Knowlton DR, et al. Evidence that protection against rotavirus diarrhea following natural infection is not dependent on serotype-specific neutralizing antibody. J Infect Dis 1992; 166:1251-7.
34. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infection in infants as protection against subsequent infections. New Engl J Med 1996; 335:1022-8.
35. Ward RL, Knowlton DR, Zito ET, et al. Serological correlates of immunity in a pivotal tetravalent reassortant rotavirus vaccine trial. J Infect Dis 1997; 176:570-7.
36. + cells in resolution of rotavirus infection and protection against reinfection in mice. Virology 1995; 214:387-97.
37. Franco MA, Greenberg HB. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol 1995; 69:7800-6.
38. McNeal MM, Vancott JL, Choi AHC, et al. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT (R192G). J Virol 2002; 76:5608.
39. Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB. Protective effect of rotavirus VP6-specific Ig A monoclonal antibodies that lack neutralizing activity. Science 1996; 272:104-7.